Journal ArticleDOI
In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles.
Gregory M. Lanza,Dana R. Abendschein,Christopher S. Hall,Michael J. Scott,David E. Scherrer,Andrew Houseman,James G. Miller,Samuel A. Wickline +7 more
Reads0
Chats0
TLDR
It is demonstrated that this novel nanoemulsion can infiltrate into arterial walls after balloon injury and localize the expression of overstretch-induced tissue factor within pig carotid arteries.Abstract:
Molecular imaging permits tissues to be functionally characterized by identification of specific cell-surface receptors with targeted contrast agents. In our study, a ligand-targeted acoustic nanoparticle system was used to identify the angioplasty-induced expression of tissue factor by smooth muscle cells within the tunica media. Pig carotid arteries were overstretched bilaterally with balloon catheters, treated with a tissue factor–targeted or a control nanoparticle system, and imaged with intravascular ultrasound (20 MHz) before and after treatment. Carotid wall acoustic reflectivities were unaffected by overstretch injury. Tissue factor–targeted nanoemulsion bound and increased the echogenicity of smooth muscle cells expressing tissue factor within the tunica media. The targeted emulsion increased the arterial wall gray scale (99.4 ± 14.5; P P Pread more
Citations
More filters
Journal ArticleDOI
Nanoparticles in cellular drug delivery.
Amir H. Faraji,Peter Wipf +1 more
TL;DR: The evaluation of targeted nanoparticles in the treatment of cancers and diseases of the central nervous system, such as glioblastoma multiforme, neurovascular disorders, and neurodegenerative diseases, is discussed.
Journal ArticleDOI
Nanoplatforms for targeted molecular imaging in living subjects.
Weibo Cai,Xiaoyuan Chen +1 more
TL;DR: The current state-of-the-art of nanoplatforms for targeted molecular imaging in living subjects is summarized.
Journal ArticleDOI
Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives
TL;DR: This manuscript reviews the development and application of nanoparticles and their future potential to advance current and emerging clinical bioimaging techniques, with a focus on solid, phase-separated materials, for example metals and metal oxides.
Journal ArticleDOI
Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent Implications for Rational Therapy of Restenosis
Gregory M. Lanza,Xin Yu,Patrick M. Winter,Dana R. Abendschein,Kerry K. Karukstis,Michael J. Scott,Lori Chinen,Ralph W. Fuhrhop,David E. Scherrer,Samuel A. Wickline +9 more
TL;DR: Data suggest that targeted paramagnetic nanoparticles may provide a novel, MRI-visualizable, and quantifiable drug delivery system for the prevention of restenosis after angioplasty.
Journal ArticleDOI
Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI
Anne M. Morawski,Patrick M. Winter,Kathryn C. Crowder,Shelton D. Caruthers,Shelton D. Caruthers,Ralph W. Fuhrhop,Michael J. Scott,J. David Robertson,Dana R. Abendschein,Gregory M. Lanza,Samuel A. Wickline +10 more
TL;DR: Quantification of the signal from cell monolayers imaged at 1.5 T demonstrated, as predicted via modeling, that only picomolar concentrations of paramagnetic perfluorocarbon nanoparticles were required for the detection and quantification of tissue factor at clinical field strengths.
References
More filters
Journal ArticleDOI
Role of tissue factor in embryonic blood vessel development
Peter Carmeliet,Nigel Mackman,Lieve Moons,Thomas Luther,Pierre Gressens,I Van Vlaenderen,H Demunck,Michael Kasper,Georg Breier,Philippe Evrard,Martin Müller,Werner Risau,Thomas S. Edgington,Desire Collen +13 more
TL;DR: It is reported that inactivation of the tissue factor gene (TF) results in abnormal circulation from yolk sac to embryo beyond embryonic day 8.5, leading to embryo wasting and death, implying that tissue factor has a role in bloodvessel development.
Journal ArticleDOI
Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature
Xianming Huang,Grietje Molema,Grietje Molema,Steven King,Linda Watkins,Thomas S. Edgington,Philip E. Thorpe +6 more
TL;DR: Intravenous administration of the antibody-tTF complex to mice with large neuroblastomas resulted in complete tumor regressions in 38 percent of the mice, indicating an effective and selective thrombogen when targeted to tumor endothelial cells.
Journal ArticleDOI
A Novel Site-Targeted Ultrasonic Contrast Agent With Broad Biomedical Application
Gregory M. Lanza,Kirk D. Wallace,Michael J. Scott,William P. Cacheris,Dana R. Abendschein,Donald H. Christy,Angela M. Sharkey,James G. Miller,Patrick J. Gaffney,Samuel A. Wickline +9 more
TL;DR: These data provide the first in vivo demonstration of a site-specific ultrasonic contrast agent and have potential for improved sensitivity and specificity for noninvasive diagnosis of thrombi and other pathological diseases.
Journal ArticleDOI
Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting.
F J Martin,D Papahadjopoulos +1 more
TL;DR: The present coupling method was used to coupleabbit Fab' antibody fragments to preformed large unilamellar vesicles using a new sulfhydryl-reactive phospholipid derivative N-[4-(p-maleimidophenyl)butyryl]phosphatidylethanolamine (MPB-PE).
Journal ArticleDOI
Acoustically Active Lipospheres Containing Paclitaxel: A New Therapeutic Ultrasound Contrast Agent
TL;DR: Paclitaxel-carrying lipospheres (MRX-552) represent a new class of acoustically active drug delivery vehicles for ultrasound-mediated drug delivery and acute toxicity studies in mice showed a 10-fold reduction in toxicity for paclitaxe in AALs compared with free pac litaxel.